Search Results

There are 1543 results for: content related to: Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

  1. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 12, Issue 6, June 2006, Pages: 524–534, Michael R. Konikoff and Lee A. Denson

    Article first published online : 14 DEC 2006, DOI: 10.1097/00054725-200606000-00013

  2. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6

    Clinical & Experimental Allergy

    Volume 45, Issue 5, May 2015, Pages: 928–939, L. Orivuori, K. Mustonen, M. C. de Goffau, S. Hakala, M. Paasela, C. Roduit, J.-C. Dalphin, J. Genuneit, R. Lauener, J. Riedler, J. Weber, E. von Mutius, J. Pekkanen, H. J. M. Harmsen, O. Vaarala and the PASTURE Study Group

    Article first published online : 16 APR 2015, DOI: 10.1111/cea.12522

  3. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

    Inflammatory Bowel Diseases

    Volume 15, Issue 8, August 2009, Pages: 1190–1198, Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco and José Maté

    Article first published online : 16 MAR 2009, DOI: 10.1002/ibd.20933

  4. You have free access to this content
    Emerging role of calprotectin in gastroenterology

    Journal of Gastroenterology and Hepatology

    Volume 18, Issue 7, July 2003, Pages: 756–762, ANDREW POULLIS, RUSSELL FOSTER, MICHAEL A MENDALL and MAGNE K FAGERHOL

    Article first published online : 10 JUN 2003, DOI: 10.1046/j.1440-1746.2003.03014.x

  5. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis

    Liver International

    Volume 31, Issue 9, October 2011, Pages: 1406–1415, Felix Gundling, Fabian Schmidtler, Alexander Hapfelmeier, Benjamin Schulte, Thomas Schmidt, Christian Pehl, Wolfgang Schepp and Holger Seidl

    Article first published online : 6 SEP 2011, DOI: 10.1111/j.1478-3231.2011.02577.x

  6. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2218–2224, Geert D'Haens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen and Paul Rutgeerts

    Article first published online : 16 FEB 2012, DOI: 10.1002/ibd.22917

  7. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings

    Inflammatory Bowel Diseases

    Volume 14, Issue 1, January 2008, Pages: 40–46, Taina Sipponen, Erkki Savilahti, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen and Martti Färkkilä

    Article first published online : 16 NOV 2007, DOI: 10.1002/ibd.20312

  8. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases

    Inflammatory Bowel Diseases

    Volume 14, Issue 9, September 2008, Pages: 1229–1235, A. Diamanti, F. Colistro, M. S. Basso, B. Papadatou, P. Francalanci, F. Bracci, M. Muraca, D. Knafelz, P. De Angelis and M. Castro

    Article first published online : 8 APR 2008, DOI: 10.1002/ibd.20472

  9. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 15, Issue 5, May 2009, Pages: 756–759, Michael A. Quail, Richard K. Russell, Johan E. Van Limbergen, Pam Rogers, Hazel E. Drummond, David C. Wilson and Peter M. Gillett

    Article first published online : 23 DEC 2008, DOI: 10.1002/ibd.20820

  10. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

    Inflammatory Bowel Diseases

    Volume 14, Issue 3, March 2008, Pages: 359–366, Marc A. Sidler, Steven T. Leach and Andrew S. Day

    Article first published online : 29 NOV 2007, DOI: 10.1002/ibd.20336

  11. You have free access to this content
    Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

    Journal of Internal Medicine

    Volume 270, Issue 1, July 2011, Pages: 50–57, K. Andréasson, A. Scheja, T. Saxne, B. Ohlsson and R. Hesselstrand

    Article first published online : 9 JAN 2011, DOI: 10.1111/j.1365-2796.2010.02340.x

  12. Diagnostic work-up of inflammatory bowel disease in children: The role of calprotectin assay

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1926–1930, A. Diamanti, F. Panetta, M.S. Basso, A. Forgione, F. Colistro, F. Bracci, B. Papadatou, P. Francalanci, F. Torroni, D. Knafelz, F. Fina and M. Castro

    Article first published online : 22 MAR 2010, DOI: 10.1002/ibd.21257

  13. Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 16, Issue 3, March 2010, Pages: 482–486, Mikko P. Pakarinen, Antti Koivusalo, Johanna Natunen, Merja Ashorn, Riitta Karikoski, Petri Aitola, Risto J. Rintala and Kaija-Leena Kolho

    Article first published online : 14 AUG 2009, DOI: 10.1002/ibd.21069

  14. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2018–2025, Patrick F. van Rheenen

    Article first published online : 24 JAN 2012, DOI: 10.1002/ibd.22896

  15. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

    Inflammatory Bowel Diseases

    Volume 14, Issue 10, October 2008, Pages: 1392–1398, Taina Sipponen, Erkki Savilahti, Päivi Kärkkäinen, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen and Martti Färkkilä

    Article first published online : 17 MAY 2008, DOI: 10.1002/ibd.20490

  16. Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes

    British Journal of Dermatology

    Volume 149, Issue 3, September 2003, Pages: 484–491, G. Mørk, H. Schjerven, L. Mangschau, E. Søyland and P. Brandtzaeg

    Article first published online : 23 SEP 2003, DOI: 10.1046/j.1365-2133.2003.05536.x

  17. Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis

    Journal of Periodontal Research

    Volume 46, Issue 4, August 2011, Pages: 417–426, D. Kaner, J.-P. Bernimoulin, T. Dietrich, B.-M. Kleber and A. Friedmann

    Article first published online : 13 APR 2011, DOI: 10.1111/j.1600-0765.2011.01355.x

  18. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren’s syndrome but decreased by HIV infection

    Oral Microbiology and Immunology

    Volume 16, Issue 2, April 2001, Pages: 119–123, S. P. Sweet, A. N. Denbury and S. J. Challacombe

    Article first published online : 21 DEC 2001, DOI: 10.1034/j.1399-302x.2001.016002119.x

  19. Induction of calprotectin release by Porphyromonasgingivalis lipopolysaccharide in human neutrophils

    Oral Microbiology and Immunology

    Volume 19, Issue 3, June 2004, Pages: 182–187, J. Kido, R. Kido, Suryono, M. Kataoka, M. K. Fagerhol and T. Nagata

    Article first published online : 26 APR 2004, DOI: 10.1111/j.0902-0055.2004.00139.x

  20. Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process?

    European Journal of Neuroscience

    Volume 24, Issue 12, December 2006, Pages: 3561–3566, Russell Foster, Apsara Kandanearatchi, Claire Beasley, Brenda Williams, Nadeem Khan, Magne K. Fagerhol and Ian P. Everall

    Article first published online : 12 DEC 2006, DOI: 10.1111/j.1460-9568.2006.05219.x